Pharmacoeconomic Evaluation of Qinxiang Qingjie Oral Liquid in the Treatment of Upper Respiratory Tract Infection in Children

Hu Haiyao, Han Chenglong, He Huilin, Gou Liangwen, Hu Ming

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (8) : 844-851.

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (8) : 844-851. DOI: 10.16153/j.1002-7777.2022.08.001
Supervision Administration

Pharmacoeconomic Evaluation of Qinxiang Qingjie Oral Liquid in the Treatment of Upper Respiratory Tract Infection in Children

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(8): 844-851 https://doi.org/10.16153/j.1002-7777.2022.08.001

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉